We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAJ
676
DELISTED
Canon, Inc.
CAJ
| $2.66M | 0.01% |
97,388
+52,700
| +118% | +$1.45M |
|
677
Sanofi
SNY
$104B
| $2.65M | 0.01% |
52,842
-789
| -1% | -$37K |
|
678
International Flavors & Fragrances
IFF
$19.4B
| $2.65M | 0.01% |
20,520
+1,195
| +6% | +$153K |
|
679
Woodward
WWD
$25B
| $2.65M | 0.01% |
22,361
-558
| -2% | -$63K |
|
680
Reinsurance Group of America
RGA
$15.7B
| $2.63M | 0.01% |
16,119
-78
| -0.5% | -$12.6K |
|
681
Williams-Sonoma
WSM
$26.7B
| $2.62M | 0.01% |
71,450
-4,816
| -6% | -$167K |
|
682
Schneider National
SNDR
$6.59B
| $2.62M | 0.01% |
120,152
-249
| -0.2% | -$5.6K |
|
683
Universal Health Services
UHS
$9.43B
| $2.62M | 0.01% |
18,269
+1,015
| +6% | +$145K |
|
684
HCA Healthcare
HCA
$84.8B
| $2.62M | 0.01% |
17,695
+133
| +0.8% | +$17.9K |
|
685
ORIX
IX
$44B
| $2.6M | 0.01% |
155,820
+34,675
| +29% | +$556K |
|
686
WesBanco
WSBC
$3.95B
| $2.56M | 0.01% |
67,740
-4,531
| -6% | -$169K |
|
687
IPG Photonics
IPGP
$3.89B
| $2.56M | 0.01% |
17,636
+979
| +6% | +$136K |
|
688
FirstEnergy
FE
$28.9B
| $2.55M | 0.01% |
52,535
-709
| -1% | -$33.9K |
|
689
Middleby
MIDD
$6.05B
| $2.55M | 0.01% |
23,301
+804
| +4% | +$92.3K |
|
|
ABB
690
DELISTED
ABB Ltd
ABB
| $2.55M | 0.01% |
105,871
-9,415
| -8% | -$202K |
|
691
Alexandria Real Estate Equities
ARE
$8.88B
| $2.55M | 0.01% |
15,764
-344
| -2% | -$54.2K |
|
|
CYBR
692
DELISTED
CyberArk
CYBR
| $2.54M | 0.01% |
21,736
+11,586
| +114% | +$1.3M |
|
693
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.2B
| $2.53M | 0.01% |
43,451
-184
| -0.4% | -$10.7K |
|
694
Franco-Nevada
FNV
$41.4B
| $2.53M | 0.01% |
24,495
+901
| +4% | +$87.1K |
|
695
ESCO Technologies
ESE
$8.49B
| $2.53M | 0.01% |
27,326
-636
| -2% | -$54.2K |
|
696
Fortune Brands Innovations
FBIN
$6.12B
| $2.52M | 0.01% |
45,111
-1,455
| -3% | -$76.5K |
|
697
Nasdaq
NDAQ
$51.5B
| $2.48M | 0.01% |
69,357
+1,008
| +1% | +$34.4K |
|
698
Manulife Financial
MFC
$72.6B
| $2.47M | 0.01% |
121,645
-8,056
| -6% | -$154K |
|
699
Morningstar
MORN
$6.56B
| $2.46M | 0.01% |
16,290
-506
| -3% | -$77.7K |
|
700
Plexus
PLXS
$6.81B
| $2.46M | 0.01% |
32,036
+4,639
| +17% | +$337K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.